[HTML][HTML] Application of radiomics in diagnosis and treatment of lung cancer
F Pan, L Feng, B Liu, Y Hu, Q Wang - Frontiers in Pharmacology, 2023 - frontiersin.org
Radiomics has become a research field that involves the process of converting standard
nursing images into quantitative image data, which can be combined with other data …
nursing images into quantitative image data, which can be combined with other data …
[HTML][HTML] Advances in the molecular landscape of lung cancer brain metastasis
VGP Souza, RP de Araújo, MR Santesso, AL Seneda… - Cancers, 2023 - mdpi.com
Simple Summary Patients with lung cancer have high rates of brain metastasis (BM).
Despite available therapies, patient prognosis is poor. Studies have shown genetic …
Despite available therapies, patient prognosis is poor. Studies have shown genetic …
Automated detection and segmentation of brain metastases in malignant melanoma: evaluation of a dedicated deep learning model
L Pennig, R Shahzad, L Caldeira… - American Journal …, 2021 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Malignant melanoma is an aggressive skin cancer in
which brain metastases are common. Our aim was to establish and evaluate a deep …
which brain metastases are common. Our aim was to establish and evaluate a deep …
Genomic alterations and the incidence of brain metastases in advanced and metastatic non-small cell lung cancer: a systematic review and meta-analysis
CS Gillespie, MA Mustafa, GE Richardson… - Journal of Thoracic …, 2023 - Elsevier
Background Brain metastases (BM) in patients with advanced and metastatic non-small cell
lung cancer (NSCLC) are linked with poor prognosis. Identifying genomic alterations …
lung cancer (NSCLC) are linked with poor prognosis. Identifying genomic alterations …
[HTML][HTML] The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review
L Berzenji, S Debaenst, JMH Hendriks… - … lung cancer research, 2021 - ncbi.nlm.nih.gov
Objective In this review, we aim to summarize the most recent data on the surgical
management of oligometastatic non-small cell lung cancer (NSCLC). Background …
management of oligometastatic non-small cell lung cancer (NSCLC). Background …
[HTML][HTML] Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review)
M Łazar-Poniatowska, A Bandura… - … lung cancer research, 2021 - ncbi.nlm.nih.gov
Concurrent chemoradiotherapy (CHRT) remains the therapeutic standard for locally
advanced inoperable non-small-cell lung cancer (NSCLC). The median overall survival (OS) …
advanced inoperable non-small-cell lung cancer (NSCLC). The median overall survival (OS) …
Treatment of advanced non-small-cell lung cancer: First line, maintenance, and second line–Indian consensus statement update (Under the aegis of Lung Cancer …
K Prabhash, A Vora, S Limaye, TP Sahoo… - Cancer Research …, 2021 - journals.lww.com
The management of patients with advanced non-small-cell lung cancer (NSCLC) is
becoming increasingly complex, with the identification of driver mutations/rearrangements …
becoming increasingly complex, with the identification of driver mutations/rearrangements …
[HTML][HTML] Trends in the epidemiology of small-cell lung cancer: a Dutch nationwide population-based study over 1989–2020
DW Dumoulin, MJ Aarts, D De Ruysscher… - European Journal of …, 2023 - Elsevier
Introduction This study describes the evolving characteristics of patients with small-cell lung
cancer (SCLC) from 1989 to 2020 in the Netherlands to analyse how the population of …
cancer (SCLC) from 1989 to 2020 in the Netherlands to analyse how the population of …
[HTML][HTML] Memantine for prevention of brain irradiation–induced cognitive toxicity: A tale of an underappreciated and underused intervention
S Chilukuri, N Burela - JCO Global Oncology, 2020 - ncbi.nlm.nih.gov
There is now a strong emphasis on limiting the use of whole-brain radiation therapy (WBRT)
in patients with brain metastases because of the well-known spectrum of acute, subacute …
in patients with brain metastases because of the well-known spectrum of acute, subacute …
[HTML][HTML] Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer …
JJAO Schoenmaekers, MS Paats… - Translational Lung …, 2020 - ncbi.nlm.nih.gov
Up to 70% of non-small cell lung cancer (NSCLC) patients develop central nervous system
(CNS) metastases during the course of their disease, especially those with oncogenic …
(CNS) metastases during the course of their disease, especially those with oncogenic …